ArticleScientific reports2026
Evaluation of ChatGPT-4o and Gemini for gout management: a comparative analysis based on EULAR guidelines.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gout is the most common form of inflammatory arthritis, with a growing global prevalence and significant clinical burden. Although effective treatments are available, real-world implementation of guideline-based care remains suboptimal. This study aimed to comparatively evaluate the performance of two large language models (LLMs), ChatGPT-4o and Gemini 2.0 Flash, in responding to structured clinical questions derived from the 2018 and 2016 EULAR guidelines for the diagnosis and management of gout. Both models demonstrated moderate reliability and high response quality. Regarding guideline alignment, ChatGPT-4o provided fully aligned, complete, and accurate responses to 76.0% of the questions, whereas Gemini achieved this in 48.0%. Additionally, 8.0% of Gemini’s responses were entirely contradictory to the guidelines, while ChatGPT-4o had none. ChatGPT-4o significantly outperformed Gemini across reliability, quality, and alignment metrics. Readability assessments indicated that both models generated content requiring college-level comprehension. Both LLMs showed potential in supporting clinical decision-making for gout management. However, ChatGPT-4o consistently produced more accurate and guideline-concordant responses. While these tools may enhance clinical care and education, caution is warranted due to limitations in transparency and consistency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.